Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/17526
Title: | Xp11 translocation renal cell carcinoma paraneoplastic syndrome presenting as cutaneous vasculitis: first reported case of yet another mask. | Austin Authors: | Pascoe, Claire;Christidis, Daniel;Clouston, David;Lawrentschuk, Nathan | Affiliation: | Department of Urology, Austin Health, Heidelberg, Victoria, Australia YURO, Young Urology Researchers Organisation, Melbourne, Victoria, Australia Cancer Surgery, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia Department of Pathology, Tissue Path, Mount Waverley, Victoria, Australia |
Issue Date: | 21-Apr-2018 | Date: | 2018-04-21 | Publication information: | BMJ Case Reports 2018; 2018: bcr-2017-223423 | Abstract: | Renal cell carcinoma is historically known as the 'great masquerader' with 40% of patients experiencing a paraneoplastic syndrome. Translocation carcinoma represents one-third of renal cancer in paediatric patients but less than 3% of renal cancers in patients aged 18-45 years where the clinical course is often rapidly terminal. There are less than 10 reported cases of leucoclastic vasculitis associated with clear cell carcinoma reported in the literature and 10 case reports of translocation carcinoma in adults. To our knowledge, we present the first reported case of Xp11 translocation carcinoma presenting as cutaneous vasculitis, as part of a paraneoplastic syndrome, in an adult patient. Our case highlights that renal cell cancers are truly the 'great masquerader' and a rash can be the first sign of renal malignancy. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/17526 | DOI: | 10.1136/bcr-2017-223423 | ORCID: | 0000-0003-2951-3726 0000-0001-8553-5618 |
Journal: | BMJ Case Reports | PubMed URL: | 29680797 | Type: | Journal Article | Subjects: | dermatology surgical oncology urological surgery urology |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.